<--- Back to Details
First PageDocument Content
Pharmacology / Gadolinium / Gadopentetic acid / Drug safety / Gadoteric acid / Nephrogenic systemic fibrosis / Magnetic resonance imaging / Food and Drug Administration / Gadodiamide / Chemistry / Medicine / Matter
Pharmacology
Gadolinium
Gadopentetic acid
Drug safety
Gadoteric acid
Nephrogenic systemic fibrosis
Magnetic resonance imaging
Food and Drug Administration
Gadodiamide
Chemistry
Medicine
Matter

[removed]Gadoterate Clinical PREA

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 2,92 MB

Share Document on Facebook

Similar Documents

Effective Date:      , 20

Effective Date: , 20

DocID: YFKt - View Document

[removed]Gadoterate Statistical PREA

[removed]Gadoterate Statistical PREA

DocID: HRkf - View Document

FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Research Medical Imaging Drugs Advisory Committee (MIDAC) Meeting FDA White Oak Campus, Building 31, The Great Room (Rm[removed]White Oak Conference Center, Silv

FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Research Medical Imaging Drugs Advisory Committee (MIDAC) Meeting FDA White Oak Campus, Building 31, The Great Room (Rm[removed]White Oak Conference Center, Silv

DocID: lQAl - View Document

FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Research Medical Imaging Drugs Advisory Committee (MIDAC) Meeting FDA White Oak Campus, Building 31, The Great Room (Rm[removed]White Oak Conference Center, Silv

FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Research Medical Imaging Drugs Advisory Committee (MIDAC) Meeting FDA White Oak Campus, Building 31, The Great Room (Rm[removed]White Oak Conference Center, Silv

DocID: lQ0f - View Document

[removed]Gadoterate Clinical PREA

[removed]Gadoterate Clinical PREA

DocID: f18F - View Document